About all

Does heart failure hurt: Heart failure – Symptoms and causes

by alexxlab

Chronic Pain in Chronic Heart Failure: A Review Article

1. Roger VL. Epidemiology of heart failure. Circ Res. 2013;113:646–659. [PMC free article] [PubMed] [Google Scholar]

2. Johnson MJ. Management of end stage cardiac failure. Postgrad Med J. 2007;83:395–401. [PMC free article] [PubMed] [Google Scholar]

3. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–869. [PubMed] [Google Scholar]

4. Blinderman CD, Homel P, Billings JA, Portenoy RK, Tennstedt SL. Symptom distress and quality of life in patients with advanced congestive heart failure. J Pain Symptom Manage. 2008;35:594–603. [PMC free article] [PubMed] [Google Scholar]

5. Cotter G, Milo O, Davison BA. Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond. Curr Heart Fail Rep. 2014;11:19–30. [PubMed] [Google Scholar]

6. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154–235. [PubMed] [Google Scholar]

7. Nordgren L, Sörensen S. Symptoms experienced in the last six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs. 2003;2:213–217. [PubMed] [Google Scholar]

8. Ekman I, Cleland JG, Swedberg K, Charlesworth A, Metra M, Poole-Wilson PA. Symptoms in patients with heart failure are prognostic predictors: insights from COMET. J Card Fail. 2005;11:288–292. [PubMed] [Google Scholar]

9. Zambroski CH, Moser DK, Bhat G, Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4:198–206. [PubMed] [Google Scholar]

10. Godfrey C, Harrison MB, Medves J, Tranmer JE. The symptom of pain with heart failure: a systematic review. J Card Fail. 2006;12:307–313. [PubMed] [Google Scholar]

11. Sullivan M, Levy WC, Russo JE, Spertus JA. Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail. 2004;10:390–396. [PubMed] [Google Scholar]

12. Lettman NA, Sites FD, Shofer FS, Hollander JE. Congestive heart failure patients with chest pain: incidence and predictors of acute coronary syndrome. Acad Emerg Med. 2002;9:903–909. [PubMed] [Google Scholar]

13. Lip G, Zarifis J, Beevers DG. Acute admissions with heart failure to a district general hospital serving a multiracial population. Int J Clin Pract. 1997;51:223–227. [PubMed] [Google Scholar]

14. Whelan CT, Jin L, Meltzer D. Pain and satisfaction with pain control in hospitalized medical patients: no such thing as low risk. Arch Intern Med. 2004;164:175–180. [PubMed] [Google Scholar]

15. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA. 1998;280:147–151. [PubMed] [Google Scholar]

16. Godfrey CM, Harrison MB, Friedberg E, Medves JM, Tranmer JE. The symptom of pain in individuals recently hospitalized for heart failure. J Cardiovasc Nurs. 2007;22:368–374. [PubMed] [Google Scholar]

17. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health. 1997;87:643–648. [PMC free article] [PubMed] [Google Scholar]

18. Goebel JR, Doering LV, Evangelista LS, Nyamathi AM, Maliski SL, Asch SM, Sherbourne CD, Shugarman LR, Lanto AB, Cohen A, Lorenz KA. A comparative study of pain in heart failure and non-heart failure veterans. J Card Fail. 2009;15:24–30. [PMC free article] [PubMed] [Google Scholar]

19. Conley S, Feder S, Redeker NS. The relationship between pain, fatigue, depression and functional performance in stable heart failure. Heart Lung. 2015;44:107–112. [PMC free article] [PubMed] [Google Scholar]

20. Conley S, Feder S, Redeker NS. The relationship between pain, fatigue, depression and functional performance in stable heart failure. Heart Lung. 2015;44:107–112. [PMC free article] [PubMed] [Google Scholar]

21. Evangelista LS, Berg J, Dracup K. Relationship between psychosocial variables and compliance in patients with heart failure. Heart Lung. 2001;30:294–301. [PubMed] [Google Scholar]

22. Goodlin SJ, Wingate S, Albert NM, Pressler SJ, Houser J, Kwon J, Chiong J, Storey CP, Quill T, Teerlink JR PAIN-HF Investigators. Investigating pain in heart failure patients: the pain assessment, incidence, and nature in heart failure (PAIN-HF) study. J Card Fail. 2012;18:776–783. [PubMed] [Google Scholar]

23. Rustøen T, Stubhaug A, Eidsmo I, Westheim A, Paul SM, Miaskowski C. Pain and quality of life in hospitalized patients with heart failure. J Pain Symptom Manage. 2008;36:497–504. [PubMed] [Google Scholar]

24. Shah AB, Udeoji DU, Baraghoush A, Bharadwaj P, Yennurajalingam S, Schwarz ER. An evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med. 2013;16:87–90. [PubMed] [Google Scholar]

25. Udeoji DU, Shah AB, Bharadwaj P, Katsiyiannis P, Schwarz ER. Evaluation of the prevalence and severity of pain in patients with stable chronic heart failure. World J Cardiol. 2012;4:250–255. [PMC free article] [PubMed] [Google Scholar]

26. Gan Q, Zhang FR, Zhou QF, Dai LY, Liu YH, Chai XC, Wu F, Shen WF. Clinical significance of pain in patients with chronic heart failure. Chin Med J (Engl) 2012;125:3223–3227. [PubMed] [Google Scholar]

27. Pantilat SZ, O’Riordan DL, Rathfon MA, Dracup KA, De Marco T. Etiology of pain and its association with quality of life among patients with heart failure. J Palliat Med. 2016;19:1254–1259. [PubMed] [Google Scholar]

28. Evangelista LS, Sackett E, Dracup K. Pain and heart failure: unrecognized and untreated. Eur J Cardiovasc Nurs. 2009;8:169–173. [PMC free article] [PubMed] [Google Scholar]

29. Bekelman DB, Havranek EP, Becker DM, Kutner JS, Peterson PN, Wittstein IS, Gottlieb SH, Yamashita TE, Fairclough DL, Dy SM. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail. 2007;13:643–648. [PubMed] [Google Scholar]

30. Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc. 2000;48:S101–109. [PubMed] [Google Scholar]

31. Desbiens NA, Mueller-Rizner N, Connors AF, Wenger NS. The relationship of nausea and dyspnea to pain in seriously ill patients. Pain. 1997;71:149–156. [PubMed] [Google Scholar]

32. Desbiens NA, Wu AW, Alzola C, Mueller-Rizner N, Wenger NS, Connors AF Jr, Lynn J, Phillips RS. Pain during hospitalization is associated with continued pain six months later in survivors of serious illness. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Med. 1997;102:269–276. [PubMed] [Google Scholar]

33. Desbiens NA, Wu AW, Broste SK, Wenger NS, Connors AF Jr, Lynn J, Yasui Y, Phillips RS, Fulkerson W. Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations. For the SUPPORT investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatmentm. Crit Care Med. 1996;24:1953–1961. [PubMed] [Google Scholar]

34. Goodlin SJ, Wingate S, Pressler SJ, Teerlink JR, Storey CP. Investigating pain in heart failure patients: rationale and design of the Pain Assessment, Incidence & Nature in Heart Failure (PAIN-HF) study. J Card Fail. 2008;14:276–282. [PubMed] [Google Scholar]

35. Goodlin SJ. Care of the older patient with pain. Curr Pain Headache Rep. 2004;8:277–280. [PubMed] [Google Scholar]

36. Fan H, Yu W, Zhang Q, Cao H, Li J, Wang J, Shao Y, Hu X. Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis. Prev Med. 2014;63:36–42. [PubMed] [Google Scholar]

37. Schäfers M, Sommer C, Geis C, Hagenacker T, Vandenabeele P, Sorkin LS. Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro. Neuroscience. 2008;157:414–423. [PubMed] [Google Scholar]

38. Kalogeropoulos A, Georgiopoulou V, Psaty BM, Rodondi N, Smith AL, Harrison DG, Liu Y, Hoffmann U, Bauer DC, Newman AB, Kritchevsky SB, Harris TB, Butler J Health ABC Study Investigators. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol. 2010;55:2129–2137. [PMC free article] [PubMed] [Google Scholar]

39. Kleinbongard P, Heusch G, Schulz R. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther. 2010;127:295–314. [PubMed] [Google Scholar]

40. Saunders DC, Baines M. Living with Dying. In: Saunders DC, editor. Living with Dying: The Management of Terminal Disease. 2nd ed. . New York: Oxford University Press; 1989. pp. 110–114. [Google Scholar]

41. Light-McGroary K, Goodlin SJ. The challenges of understanding and managing pain in the heart failure patient. Curr Opin Support Palliat Care. 2013;7:14–20. [PubMed] [Google Scholar]

42. Murray SA, Kendall M, Grant E, Boyd K, Barclay S, Sheikh A. Patterns of social, psychological, and spiritual decline toward the end of life in lung cancer and heart failure. J Pain Symptom Manage. 2007;34:393–402. [PubMed] [Google Scholar]

43. Anderson H, Ward C, Eardley A, Gomm SA, Connolly M, Coppinger T, Corgie D, Williams JL, Makin WP. The concerns of patients under palliative care and a heart failure clinic are not being met. Palliat Med. 2001;15:279–286. [PubMed] [Google Scholar]

44. Goebel JR, Doering LV, Shugarman LR, Asch SM, Sherbourne CD, Lanto AB, Evangelista LS, Nyamathi AM, Maliski SL, Lorenz KA. Heart failure: the hidden problem of pain. J Pain Symptom Manage. 2009;38:698–707. [PMC free article] [PubMed] [Google Scholar]

45. Christiansen I, Iversen HK, Olesen J. Headache characteristics during the development of tolerance to nitrates: pathophysiological implications. Cephalalgia. 2000;20:437–444. [PubMed] [Google Scholar]

46. Hauptman PJ, Goodlin SJ, Lopatin M, Costanzo MR, Fonarow GC, Yancy CW. Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. Arch Intern Med. 2007;167:1990–1997. [PubMed] [Google Scholar]

47. Kapur BM, Lala PK, Shaw JL. Pharmacogenetics of chronic pain management. Clin Biochem. 2014;47:1169–1187. [PubMed] [Google Scholar]

48. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116:4–15. [PMC free article] [PubMed] [Google Scholar]

49. Mukherjee D. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor. Thromb Haemost. 2006;96:407–412. [PubMed] [Google Scholar]

50. Manchikanti L, Ailinani H, Koyyalagunta D, Datta S, Singh V, Eriator I, Sehgal N, Shah R, Benyamin R, Vallejo R, Fellows B, Christo PJ. A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician. 2011;14:91–121. [PubMed] [Google Scholar]

51. Sansone RA, Sansone LA. Pain, pain, go away: antidepressants and pain management. Psychiatry (Edgmont) 2008;5:16–19. [PMC free article] [PubMed] [Google Scholar]

52. Loder E. Triptan therapy in migraine. N Engl J Med. 2010;363:63–70. [PubMed] [Google Scholar]

53. Clark AJ, Lynch ME, Ware M, Beaulieu P, McGilveray IJ, Gourlay D. Guidelines for the use of cannabinoid compounds in chronic pain. Pain Res Manag. 2005;10 (Suppl A):44A–46A. [PubMed] [Google Scholar]

54. Gielen S, Adams V, Möbius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 2003;42:861–868. [PubMed] [Google Scholar]

55. Adamopoulos S, Parissis J, Karatzas D, Kroupis C, Georgiadis M, Karavolias G, Paraskevaidis J, Koniavitou K, Coats AJ, Kremastinos DT. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure. J Am Coll Cardiol. 2002;39:653–663. [PubMed] [Google Scholar]

56. McDonald DD, Soutar C, Chan MA, Afriyie A. A closer look: alternative pain management practices by heart failure patients with chronic pain. Heart Lung. 2015;44:395–399. [PubMed] [Google Scholar]

Dealing with Chest Pain and Heart Failure




New

ESC Guidelines for Heart Failure – what patients need to know


Learn more


Choose your language





  • Increase text size
    Decrease text size


  • Print this page




  • Email this page


Pain due to heart problems is usually felt in the chest, although it can be located anywhere between the upper abdomen (upper trunk) and throat, including the arms and shoulders. It can be experienced as discomfort, pressure, gas, or a burning or aching feeling.

Chest pain should ALWAYS be treated as serious as it could indicate a worsening of your heart failure, angina or a heart attack. You should sit or lie down immediately and rest.

If you experience chest discomfort or pain that lasts for more than 15 minutes or is not relieved by rest or glyceryl trinitrate (GTN/nitroglycerin) (if you have been prescribed this by your doctor), then you should call for emergency help immediately.


ESC Guidelines for Heart Failure

What patients need to know

This guide for patients from the European Society of Cardiology aims to provide an overview of the latest evidence-based recommendations for the diagnosis and treatment of heart failure.

In particular, it should help patients to understand the:

  • main types of heart failure
  • medicines used to treat heart failure
  • devices that may be appropriate
  • importance of rehabilitation
  • management by a multidisciplinary team
  • importance of self-care in managing your own condition


Learn more





Download the Guidelines

AN ANIMATED JOURNEY THROUGH HEART FAILURE

A series of 9 simple, captivating animations explaining heart failure and its treatment.

These narrated animations explain how a healthy heart works, what happens to it in heart failure and how various treatments work to improve your health.



How the normal heart works



What goes wrong in heart failure



How the heart and body compensate in heart failure



How heart failure causes fluid accumulation



How a heart attack can cause heart failure



How abnormal heart valves can cause heart failure



How vasodilators work in heart failure



How diuretics work in heart failure



How medical devices work in heart failure

PATIENT AND CAREGIVERS VIDEOS

In this section you can watch, listen or read interviews with other people with heart failure and their caregivers.




Patient in exercise training




Patient with an ICD




An LVAD as a bridge to transplantation




Adjusting lifestyle and staying optimistic




Living with heart failure devices




Challenges in making the diagnosis




Living with an LVAD

VISIT OUR FACEBOOK PAGE

and share your own views and experiences with other patients, families and caregivers.


https://www.facebook.com/heartfailurematters

heartfailurematters.org is a European Society of Cardiology website

The heartfailurematters.org website was developed under the direction of the Heart Failure Association of the European Society of Cardiology (ESC). The ESC is a world leader in the discovery and dissemination of best practices in cardiovascular medicine. Our members and decision-makers are healthcare professionals who volunteer their time and expertise to represent professionals in the field of cardiology in Europe and beyond.




Heart failure: causes, signs and symptoms

Today, heart failure has become epidemic. Every year the number of people suffering from this disease is growing all over the world. Heart failure develops as a complication of various diseases of the cardiovascular system.

In Russia, at least 8 million people suffer from heart failure. This disease is common among people of mature and old age: it mainly develops after 60 years of age

What is heart failure?

Heart failure is a condition based on a malfunction of the heart, a decrease in its “pumping” function, as a result of which the blood supply to tissues and organs is disturbed, they experience a lack of oxygen and nutrients. This failure occurs due to the fact that the heart literally runs out of strength: they are no longer enough to push blood into the vascular bed, the contractility of the myocardium decreases. To cope with this task, the heart goes into “emergency mode” – by increasing the pressure in the chambers (in the left and right ventricles and atria) of the heart itself.


Heart failure is chronic or acute.

The latter is an emergency condition requiring immediate medical intervention (an ambulance call is required). But, fortunately, acute heart failure develops less frequently.

A chronic disease may not manifest itself for a long time and develop gradually. Periods of exacerbations are replaced by a temporary lull. So a person can live for many years.

Causes of heart failure

Heart failure most often develops against the background of arterial hypertension and coronary heart disease . Also, the cause of its development can be:

  • 1

    diabetes mellitus

  • 2

    heart valve defects

  • 3

    obesity

  • 4

    cardiomyopathy

  • 5

    diseases of the pericardium and endocardium (outer and inner membranes of the heart)

  • 6

    congenital heart defects

  • 7

    excessive alcohol consumption, smoking

  • 8

    malnutrition, deficiency of vitamins and microelements

Heart failure increases the risk of hypokalemia (low potassium levels), often due to the use of diuretic drugs. Potassium preparations (Panangin) help prevent the development of cardiac glycoside toxicity (bradycardia, arrhythmia, weakness, dizziness, nausea, vomiting, abdominal pain, etc. ), which develops under conditions of hypokalemia, improve the tolerability of therapy with this group of drugs.

Signs and symptoms of heart failure

The insidiousness of this disease is that in the initial stages it is difficult to recognize. Common signs such as swelling, shortness of breath and fatigue are not taken seriously by many. In addition, other health problems give a similar picture. Therefore, an accurate diagnosis is possible only with a thorough history taking. Usually, determining the degree of heart failure, i.e. how far the disease has gone, and the verdict is made after taking an anamnesis and evaluating the following data. The more positive answers the doctor receives, the more likely the patient has heart failure:

  • 1

    dyspnoea when lying down, standing or sitting

  • 2

    weight gain

  • 3

    complaints about feeling of interruptions in the work of the heart

  • 4

    jugular vein swelling

  • 5

    Discomfort while lying in bed (lifting pillows, falling asleep sitting up, nocturnal choking)

  • 6

    edema

  • 7

    rales in lungs

  • 8

    heaviness, feeling of fullness in the right hypochondrium as a result of liver enlargement

  • 9

    increase in systolic blood pressure

  • 10

    heart gallop rhythm

Cardiologists stand up for public awareness: the more attentively a person treats himself during a period of ailment, the higher the chance to help him in the early stages of the disease.

Heart failure – causes, symptoms, signs, diagnosis, treatment, prevention

Classification

Causes

Symptoms

Diagnosis

Treatment

Heart failure is a clinical condition in which the activity of the heart is disrupted and it is not able to provide the body’s need for oxygen in accordance with its need.

Heart failure (HF) is a sign of decompensation of other diseases: both acute and chronic.

Classification

There are a number of classifications based on organic damage to various parts of the heart, clinical examination data, and the degree of impairment of the patient’s quality of life.

Downstream heart failure is:

  • acute;
  • chronic.

Based on the physical examination of the patient, the following classes are distinguished on the Killip scale:

  • I – without signs of heart failure;
  • II – with mild signs of heart failure, few wheezing in the lungs;
  • III – with more pronounced signs of heart failure, a lot of wheezing in the lungs;
  • IV – with signs of cardiogenic shock, systolic pressure not higher than 90 mm. rt. Art.

According to the New York Society of Cardiology, the following functional classes (FC according to NYHA) are distinguished:

  • I FC – normal physical activity is not impaired, severe weakness, shortness of breath, palpitations do not occur after exercise;
  • II FC – physical activity is moderately limited, habitual physical activity leads to fatigue, weakness, shortness of breath, palpitations, but absent at rest;
  • III FC – physical activity is significantly limited, symptoms occur with less physical exertion than the patient is used to, there are no symptoms at rest;
  • IV FC – in peace and with any type of physical activity, symptoms of the disease appear.

Variants of heart failure, taking into account data on the contractility of the left heart (left ventricular ejection fraction – LVEF):

  • with low LVEF – below 40%;
  • with an intermediate LVEF – from 40% to 49%;
  • with preserved LVEF – from 50% and above.

Stages of chronic heart failure according to Vasilenko-Strazhesko:

  • I – symptoms appear during exercise, absent at rest, there are changes in the work of the left ventricle;
  • II – there are signs of congestion in the large and / or small circles of blood circulation, remaining at rest;
  • III – a pronounced decrease in tissue oxygenation, congestion in the body with impaired hemodynamics, with dysfunction of the liver, lungs, kidneys (treatment is practically ineffective against the background of exhaustion of the body).

The risk of death in women and men with signs of heart failure is equally high, regardless of the functional class. This is due to the fact that the disease is unstable.

Causes

Older people are more likely to suffer from heart failure due to development and decompensation:

  • coronary heart disease;
  • hypertension;
  • acute myocardial infarction;
  • cardiomyopathy;
  • arrhythmias;
  • diabetes mellitus;
  • chronic obstructive pulmonary disease;
  • myocarditis.

Factors that adversely affect the body, increasing the possibility of developing the disease:

  • tobacco smoking and alcohol consumption in hepatotoxic doses;
  • overweight and obesity;
  • metabolic changes;
  • dyslipidemia;
  • endocrine dysfunction;
  • reduced physical activity;
  • stress.

As the cause of the development of heart failure, genetic predisposition, anomalies in the development of the heart and blood vessels are of great importance.

Symptoms

In the early stages, the disease can be asymptomatic, while changes in the body can be detected during examinations, tests with physical activity.

At various stages of the disease, the following signs can be detected:

  1. Dyspnea, shortness of breath. In the later stages of heart failure, shortness of breath occurs even when eating.
  2. Cough as a sign of congestion in the pulmonary circulation. With inefficient work of the left ventricle, the hydrostatic pressure in the lungs increases, the liquid part of the blood sweats into the lumen of the alveoli. Cough often occurs after sleep.
  3. Edema. A sign of congestion in the systemic circulation (dysfunction to a greater extent of the right ventricle). Ascending edema begins in the legs. They can manifest as ascites (sweating of the liquid part of the blood into the peritoneal cavity), enlargement of the liver, spleen, hydrothorax (sweating of the liquid part of the blood into the pleural cavity), anasarca (swelling of the whole body). During the examination, the swollen tissues are soft, after pressing on the skin of the lower leg, a dimple remains, on the hips and back there is a symptom of “orange peel”.
  4. Palpitations, increased heart rate (manifestation of the compensatory capabilities of the heart, aimed at increasing the minute volume of blood).
  5. Weakness, fatigue, sleep disturbance, decreased exercise tolerance. The result of chronic hypoxia and microcirculation disorders.
  6. Inability to sleep without a high pillow (manifestation of congestive heart failure in the pulmonary circulation).

Symptoms of heart failure depend not only on the stage of the disease itself, but also on the presence of concomitant pathology of the body.

Diagnostics

Given the severity of the development of the pathological process, diagnosis and care for heart failure begins when transported by ambulance to a medical facility (for example, with the development of acute myocardial infarction). Examination of a patient with a chronic form of the disease is carried out in an outpatient clinic or in a hospital setting.

Statistical data indicate that people in half of the cases seek medical help already with pronounced symptoms of the disease, structural and functional changes in other organs.

Examination may include:

  1. Collection of complaints and anamnesis (medical and life histories). The doctor carefully listens to the patient’s complaints and details them, specifies the duration of the disease, the severity of symptoms, medication, the presence of concomitant diseases, disability.
  2. Physical examination. The disease is characterized by such signs as: swelling of the cervical veins, hepatojugular reflux (when pressing on the abdomen at the site of the projection of the liver, the jugular veins swell on the neck), an increase in the boundaries of the heart, displacement of the apex beat (determined by percussion), a gallop rhythm when listening to the heart .
  3. A laboratory study includes a complete blood count, a general urinalysis, blood glucose, a biochemical blood test (ALT, AST, bilirubin, alkaline phosphatase, urea, uric acid, creatinine, total protein, albumin, ferritin), electrolytes in the blood (calcium, potassium, sodium), lipidogram, coagulogram, NUP (natriuretic peptide), thyroid hormones.
  4. Instrumental study: 12-lead ECG, Holter ECG monitoring, ultrasound of the heart, chest X-ray, Doppler – EchoCG with a study of pressure in the pulmonary artery, indicators of diastolic function of the left ventricle, myocardial biopsy, radionuclide ventriculography, coronary ventriculography.
  5. Consulting by specialists of a narrow profile.

A complete examination plan is drawn up by the attending physician individually for each patient, taking into account the stage of the disease, his current condition, and the equipment of the medical institution.

Treatment

Therapy is aimed at eliminating or reducing the severity of the symptoms of the disease, reducing congestion, preventing complications and further decompensation of the underlying and concomitant diseases, and improving the quality of human life.

Comprehensive treatment is carried out, which includes methods of non-drug and drug therapy.

The physician prepares a pharmacotherapy plan, which may include:

  1. ACE inhibitors (Enalapril, Lisinopril, Perindopril). They affect the level of blood aldosterone, the increase of which is pathogenetically significant in the development of hypertension, heart failure.
  2. Aldosterone receptor antagonists (Valsartan, Losartan).
  3. Aldosterone antagonists (spironolactone).
  4. Beta-blockers (Bisoprolol, Metoprolol, Carvedilol, Nebivolol). They have a protective effect on the myocardium, slowing down its remodeling.
  5. Diuretics (Furosemide, Torasemide). Reduce tissue swelling.
  6. Cardiac glycosides (Digoxin, Strofantin, Lanatoside C, lily of the valley preparations). Improve the contractility of the heart.
  7. Means of sympathomimetic action for parenteral use (Dopamine, Dobutamine). They are used in the later stages of the disease, in a hospital and under the strict supervision of a physician.
  8. Anticoagulants, antiplatelet agents, nitrates, antiarrhythmic drugs – according to indications.

The regimen, doses of drugs for the treatment of heart failure periodically change depending on the course and signs of the disease, the severity of complaints.

The treatment plan may include surgical therapy to restore blood circulation in the myocardium.

Non-pharmacological treatment is an important component of therapy, both in the treatment of the current condition and in the prevention of progression of heart failure.

It includes:

  • giving up bad habits;
  • normalization of body weight;
  • compliance with the rules of rational nutrition;
  • avoidance of physical overwork, stressful situations;
  • physical activity, prevention of hypodynamia.

Treatment is long and requires considerable effort and patience from the patient.

The author of the article:

Ivanova Natalya Vladimirovna

therapist

reviews leave a review

Clinic

m. Sukharevskaya

Services

  • Title
  • Primary appointment (examination, consultation) with a cardiologist2300